(13-175) Cost Evaluation and Utilization of Rifaximin in Overt Hepatic Encephalopathy

Wednesday, December 10, 2025

3:15 PM - 4:15 PM

Location: Bayside A, Level 1

Residency Program: Harris Health System
Residency Program Type: PGY1 (Pharmacy)
Residency Program Location: Texas

Co-Author(s): Patrice A. Carmouche-Evans, Denisse I. Carbajal

Primary Author(s)